These lab-produced solutions were not created with recreational use in mind. During the nineties, John W. Huffman in addition to a team of fellow chemists at Clemson University designed a number of the initially formulas for synthetic cannabinoid receptor agonists (SCRAs), a relatives of substances that imitate the physiological and psychological i